Company / Interest Expense
Xenon Pharmaceuticals Inc. Interest Expense History
FY2018-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$484.0K
FY2020
5-year range
-
FY2018-FY2020
Trend
-66.2%
vs FY2019
Sector context
#37 of 44
Health Care
What the data says
Xenon Pharmaceuticals Inc.'s interest expense of $484,000 is lower than 84% of companies in the Health Care sector (FY2020). Improved from $1M to $484,000 over the past 2 years.
Based on SEC 10-K filings.
$484,000 in FY2020.
Improved from $1M to $484,000 over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 16% in Health CareTop 16% of 44This company $484.0K Sector average $291.0M
▼
-99.8% below sector average
Key checks
Key Insights
- In FY2020, interest expense decreased 66.2% year-over-year.
- Ranks #37 out of 44 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.51 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | $484.0K | -66.2% |
| FY2019 | $1.4M | +2.9% |
| FY2018 | $1.4M | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2020 · SEC 10-K · Updated Jun 30, 2026